The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2020

Filed:

Jan. 28, 2016
Applicant:

Regents of the University of Minnesota, Minneapolis, MN (US);

Inventors:

Dan Samuel Kaufman, La Jolla, CA (US);

David Lee Lampi Hermanson, San Diego, CA (US);

Branden Scott Moriarity, Shoreview, MN (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 14/705 (2006.01); C12N 5/16 (2006.01); A61K 39/00 (2006.01); C07K 16/30 (2006.01); A61K 35/17 (2015.01); C07K 14/47 (2006.01); C07K 14/54 (2006.01); C07K 14/725 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 35/17 (2013.01); C07K 14/4747 (2013.01); C07K 14/54 (2013.01); C07K 14/7051 (2013.01); C07K 14/70578 (2013.01); C07K 14/70596 (2013.01); A61K 2039/505 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01); C07K 2319/40 (2013.01); C07K 2319/74 (2013.01);
Abstract

This disclosure describes chimeric antigen receptors for expression in a Natural Killer (NK) cell, pharmaceutical compositions that include NK cells (and/or iPSCs) modified to express a chimeric antigen receptor, and methods involving such chimeric antigen receptors. Generally, the chimeric antigen receptor includes an ectodomain that includes an antigen recognition region, a transmembrane domain linked to the ectodomain, and an endodomain linked to the transmembrane domain. The endodomain can include a signaling peptide that activates an NK cell.


Find Patent Forward Citations

Loading…